跳至主要内容
临床试验/DRKS00010830
DRKS00010830尚未招募不适用

Establishment of new diagnostic Biomarker and Characterization of protective bone marrow niche in patients with multiple myeloma - Predict

niversitätsklinikum Freiburg0 个研究点目标入组 160 人开始时间: 2016年7月19日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • -Symptomatic, IMiD-treated MM patients
  • -MM patients under anti-myeloma therapy, containing IMiDs (vs. as controls other novel antimyeloma agents)
  • -Routine bone marrow puncture during MM patient treatment course with IMiDs
  • -Healthy persons undergoing bone surgery

排除标准

  • -<18 years of age
  • -Any kind of health and/or psychological problems which withhold the patient to understand and give his/her written informed consent to use the BM sample for this research project

研究者

相似试验

Establishment of new diagnostic Biomarker and... | 临床试验